News
DARE
3.350
+0.45%
0.015
HOLX Launches BustTheMyth Campaign for Breast Health Awareness
NASDAQ · 11h ago
US State Of Georgia's Supreme Court Reinstates Abortion Ban That Was Blocked By Lower Court
Benzinga · 4d ago
Weekly Report: what happened at DARE last week (0930-1004)?
Weekly Report · 4d ago
Weekly Report: what happened at DARE last week (0923-0927)?
Weekly Report · 09/30 10:09
Weekly Report: what happened at DARE last week (0916-0920)?
Weekly Report · 09/23 10:09
Weekly Report: what happened at DARE last week (0909-0913)?
Weekly Report · 09/16 10:04
North Dakota Judge Overturns State's Abortion Ban, Making Abortion Legal In The State
Benzinga · 09/12 17:53
Weekly Report: what happened at DARE last week (0902-0906)?
Weekly Report · 09/09 10:09
Weekly Report: what happened at DARE last week (0826-0830)?
Weekly Report · 09/02 10:11
Daré Bioscience Announces Publication In The Journal Of Sexual Medicine, Safety Findings From The Phase 2b RESPOND Clinical Study Of Sildenafil Cream, 3.6%
Benzinga · 08/26 12:13
Weekly Report: what happened at DARE last week (0819-0823)?
Weekly Report · 08/26 10:10
Weekly Report: what happened at DARE last week (0812-0816)?
Weekly Report · 08/19 10:03
Dare Bioscience Is Maintained at Buy by Jones Trading
Dow Jones · 08/16 12:08
Dare Bioscience Price Target Raised to $13.00/Share From $5.00 by Jones Trading
Dow Jones · 08/16 12:08
DARE BIOSCIENCE INC <DARE.O>: JONESTRADING RAISES TARGET PRICE TO $13 FROM $5
Reuters · 08/16 06:37
Daré Bioscience (DARE) was downgraded to a Hold Rating at Maxim Group
TipRanks · 08/15 15:35
U.S. RESEARCH ROUNDUP-Allstate, bluebird bio , Vicinity Motor
Reuters · 08/15 06:57
DARE BIOSCIENCE INC <DARE.O>: MAXIM GROUP CUTS TO HOLD FROM BUY
Reuters · 08/15 05:26
Dare Bioscience Cut to Hold From Buy by Maxim Group
Dow Jones · 08/14 16:31
Maxim Group Downgrades Dare Bioscience to Hold
Benzinga · 08/14 16:21
More
Webull provides a variety of real-time DARE stock news. You can receive the latest news about Dare Bioscience Inc through multiple platforms. This information may help you make smarter investment decisions.
About DARE
Dare Bioscience, Inc. is a biopharmaceutical company committed to advancing products for women's health. XACIATO, the Company's United States Food and Drug Administration (FDA)-approved product, vaginal gel 2%, a lincosamide antibacterial indicated for the treatment of bacterial vaginosis in female patients 12 years of age and older, which is under a global license agreement with Organon. Its clinical-stage programs include Ovaprene; Sildenafil Cream, 3.6%; DARE-HRT1; DARE-VVA1; DARE-CIN; DARE-PDM1; DARE-204 and DARE-214, and DARE-FRT1 and DARE-PTB1. Its pre-clinical stage programs include DARE-LARC1, DARE-LBT, DARE-GML, DARE-RH1 and DARE-PTB2. Ovaprene, is a hormone-free monthly intravaginal contraceptive. Sildenafil Cream, 3.6%, is a cream formulation of sildenafil, the active ingredient in Viagra, to treat female sexual arousal disorder (FSAD). DARE-HRT1, is a combination bio-identical estradiol and progesterone intravaginal ring for menopausal hormone therapy.